MANILA, Philippines — Senator Francis Tolentino on Wednesday flagged what he believes was a “sad state” of the Food and Drug Administration (FDA) enforcement unit when it comes to unregistered products.
Tolentino raised his concern during the plenary debates on the 2021 budget of the Department of Trade and Industry (DTI) in the Senate.
“May I ask, is there an agreement between the DTI and the FDA as regards enforcement because, in the FDA family, there is an enforcement unit. Apparently, parang mahina po yung ating enforcement unit [Our enforcement unit is weak],” the senator said.
He pointed to the popular liver spread brand Reno.
“Lumabas sa news yung Reno liver spread. …
Keep on reading: Citing Reno liver spread incident, Tolentino laments ‘sad state’ of FDA’s enforcers